IDEAYA Biosciences Statistics Share Statistics IDEAYA Biosciences has 87.64M
shares outstanding. The number of shares has increased by 3.67%
in one year.
Shares Outstanding 87.64M Shares Change (YoY) 3.67% Shares Change (QoQ) 0.05% Owned by Institutions (%) 99.99% Shares Floating 80.64M Failed to Deliver (FTD) Shares 1,375 FTD / Avg. Volume 0.14%
Short Selling Information The latest short interest is 9.65M, so 11.01% of the outstanding
shares have been sold short.
Short Interest 9.65M Short % of Shares Out 11.01% Short % of Float 12.99% Short Ratio (days to cover) 10.25
Valuation Ratios The PE ratio is -7.65 and the forward
PE ratio is -7.83.
IDEAYA Biosciences's PEG ratio is
-0.11.
PE Ratio -7.65 Forward PE -7.83 PS Ratio 299.87 Forward PS 56.5 PB Ratio 1.98 P/FCF Ratio -8.35 PEG Ratio -0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for IDEAYA Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 14.97,
with a Debt / Equity ratio of 0.02.
Current Ratio 14.97 Quick Ratio 14.97 Debt / Equity 0.02 Debt / EBITDA -0.06 Debt / FCF -0.08 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $53.44K Profits Per Employee $-2.1M Employee Count 131 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -30.88% in the
last 52 weeks. The beta is 0.09, so IDEAYA Biosciences's
price volatility has been higher than the market average.
Beta 0.09 52-Week Price Change -30.88% 50-Day Moving Average 23.5 200-Day Moving Average 22.01 Relative Strength Index (RSI) 63.01 Average Volume (20 Days) 1,011,504
Income Statement In the last 12 months, IDEAYA Biosciences had revenue of 7M
and earned -274.48M
in profits. Earnings per share was -3.36.
Revenue 7M Gross Profit 7M Operating Income -326.98M Net Income -274.48M EBITDA -326.98M EBIT -326.98M Earnings Per Share (EPS) -3.36
Full Income Statement Balance Sheet The company has 84.38M in cash and 19.17M in
debt, giving a net cash position of 65.21M.
Cash & Cash Equivalents 84.38M Total Debt 19.17M Net Cash 65.21M Retained Earnings -622.84M Total Assets 1.04B Working Capital 630.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -247.58M
and capital expenditures -3.86M, giving a free cash flow of -251.44M.
Operating Cash Flow -247.58M Capital Expenditures -3.86M Free Cash Flow -251.44M FCF Per Share -3.08
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -4671.07% and -3921.1%.
Gross Margin 100% Operating Margin -4671.07% Pretax Margin -3921.1% Profit Margin -3921.1% EBITDA Margin -4671.07% EBIT Margin -4671.07% FCF Margin -3592.01%
